Summit, New Jersey-based Kenvue Inc. (KVUE) is a consumer health company that develops and markets a wide range of well-known personal care, health, and wellness products across categories such as skin health, self-care, and essential health. Valued at a market cap of $46 billion, the company’s portfolio includes brands like Tylenol, Listerine, Neutrogena, Aveeno, Band-Aid, and Zyrtec.
This household and personal care products company has outpaced the broader market over the past 52 weeks. Shares of KVUE have surged 27.1% over this time frame, while the broader S&P 500 Index ($SPX) has gained 11.7%. Moreover, on a YTD basis, the stock is up 12.2% compared to SPX’s 4.7% loss.
